CLINICAL_TRIALS
trial_result
· 2009-11-17
Clinical Trial Update: Extension Study of Patients Successfully Treated by Ziprasidone in Study A1281031 [Phase 3]
Summary
Extension study update for patients successfully treated with ziprasidone in a Phase 3 trial for schizophrenia; study completed with results posted in 2009.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED | Results posted: 2009-11-17